|
|||||
|
|
The anticancer activity of the transcription inhibitor terameprocol (meso-tetra-O-methyl nordihydroguaiaretic acid) formulated for systemic administration |
|
| Authors: | Lopez Rocio A Goodman Amanda B Rhodes Melissa Blomberg Jessica A L Heller Jonathan |
| Affiliation: | Erimos Pharmaceuticals, Raleigh, North Carolina 27606, USA. ralopez@erimos.com |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |